No matching parts found
The speed and effectiveness of registering, evaluating and immunizing volunteers sets new benchmarks.
The first III trials of an inactivated COVID-19 vaccine in the United Arab Emirates are among the largest in the world in terms of volunteer recruitment, achieving 31,000 vaccinated volunteers from more than 120 nationalities in just six weeks.
The speed and effectiveness of voluntary registration, detection and vaccination established new benchmarks for 4Humanity trials of the inactivated vaccine developed through Sinopharm CNBG, one of the world’s leading vaccine manufacturers. The trials are monitored through Abu Dhabi-based G42 Healthcare in partnership with the Abu Dhabi Ministry of Health, the United Arab Emirates Ministry of Health and Prevention (MoHaP) and the Abu Dhabi Health Services Company.
Global coronavirus exceeds 25 million
United Arab Emirates conducts 87955 COVID-19 tests and reports 362 new 3 deaths
India sees something new for coronavirus cases
As the tests progress, thousands of volunteers have already gained the injection of the vaccine at the time and will continue to go through normal follow-up and fitness checks, with continuous and comprehensive fitness facilities to ensure their well-being.
Reaching this voluntary milestone means that the ADNEC vaccination centers and the Al Qarain Center in Sharjah are now closed to new volunteers, but remain open to others who inject the vaccine at the time and for other physical checkups required by the program through the approved program. protocols and established for the participation of individual volunteers.
The Abu Dhabi Ministry of Health has shown that enough volunteers are now required to complete the clinical trial, so no new registrations will be accepted as of Sunday, August 30.
Abdullah bin Mohammed Al Hamed, Chairman of the Department of Health, said: “This achievement would not have been imaginable without the help of our no-nonsense leadership and your continued support for clinical studies in the fitness sector. This is an achievement in the box of fitness and will put our country at the forefront of global research efforts to address this pandemic. “
On behalf of the Ministry of Health of Abu Dhabi, His Excellency expressed his gratitude to the volunteers who were so excited to participate in clinical trials for the greatest intelligence of humanity and for serving the country and society at large. He also praised the efforts of abu Dhabi Health Services Company doctors “SEHA” during the era beyond and his tireless work to achieve this goal.
The DoH stated that it would continue to monitor all volunteers in accordance with approved protocols for this through follow-up calls or direct interviews through the medical team.
To celebrate this national achievement, the Ministry of Health and Prevention (MOHAP), the Abu Dhabi Department of Health, Abu Dhabi Health Services Company, Sinopharm and G42 Healthcare expressed their gratitude to all volunteers for their service to humanity and clinic paintings., administrative and technical staff. Through its commitment and participation in these historical trials, the world continues to take a step towards the progression of the first proven and safe vaccine.
Commenting on the more than 31,000 volunteers, the Minister of Health and Prevention, Abdul Rahman bin Mohammed Al Owais, said: “From the outset, the leaders of the United Arab Emirates were fully committed to overcoming the COVID-19 pandemic through a global collaborative effort. The public spirit of citizens and their willingness to volunteer are strong support from the UAE’s proactive technique to what is a world-leading inactivated vaccine testing program.
“Everyone involved in trials, from volunteers to clinical and administrative staff, can be incredibly proud of what has been achieved, once the sense of unity and an unusual purpose that has animated the country over the more than five decades has already appeared.
Both inactivated vaccines were a success in Phases 1 and II of the trials without causing side effects with 100% of volunteers for those antibody-generating phases.
The prospective duration and scale of the number of volunteers will place the test at the same point as the world-renowned test numbers for such programmes, which are around 45,000 or more.
The trial is part of a series of national projects aimed at selling population fitness and strengthening UAE medical and progression capacity, adding local capacity to manufacture the vaccine.